Wedbush Starts Orchard Therapeutics (ORTX) at Outperform

November 26, 2018 6:42 AM EST
Get Alerts ORTX Hot Sheet
Price: $2.99 +1.36%

Rating Summary:
    9 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 26 | New: 41
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Wedbush analyst David Nierengarten initiates coverage on Orchard Therapeutics (NASDAQ: ORTX) with a Outperform rating and a price target of $25.00.

For an analyst ratings summary and ratings history on Orchard Therapeutics click here. For more ratings news on Orchard Therapeutics click here.

Shares of Orchard Therapeutics closed at $16.76 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage